Bellevue Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Bellevue Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$2.13K	–	381
2025 Q4	$2.13K	Sell	10 -1	-9%	-$207	﹤0.01%	431
2025 Q3	$2.19K	Sell	11 -8	-42%	-$1.49K	﹤0.01%	429
2025 Q2	$3.28K	Hold	19	–	–	﹤0.01%	393
2025 Q1	$2.96K	Buy	19 +4	+27%	+$571	﹤0.01%	387
2024 Q4	$2.06K	Hold	15	–	–	﹤0.01%	438
2024 Q3	$2.24K	Hold	15	–	–	﹤0.01%	402
2024 Q2	$2.04K	Hold	15	–	–	﹤0.01%	407
2024 Q1	$2.27K	Hold	15	–	–	﹤0.01%	394
2023 Q4	$1.89K	Hold	15	–	–	﹤0.01%	408
2023 Q3	$1.4K	Hold	15	–	–	﹤0.01%	421
2023 Q2	$1.34K	Hold	15	–	–	﹤0.01%	450
2023 Q1	$1.61K	Hold	15	–	–	﹤0.01%	444
2022 Q4	$1.81K	Hold	15	–	–	﹤0.01%	412
2022 Q3	$1K	Hold	15	–	–	﹤0.01%	457
2022 Q2	$1K	Hold	15	–	–	﹤0.01%	462
2022 Q1	$2K	Sell	15 -3	-17%	-$347	﹤0.01%	437
2021 Q4	$2K	Sell	18 -1	-5%	-$149	﹤0.01%	476
2021 Q3	$3K	Hold	19	–	–	﹤0.01%	442
2021 Q2	$2K	Sell	19 -2	-10%	-$267	﹤0.01%	502
2021 Q1	$3K	Sell	21 -3	-13%	-$456	﹤0.01%	495
2020 Q4	$4K	Buy	24 +2	+9%	+$331	﹤0.01%	452
2020 Q3	$3K	Hold	22	–	–	﹤0.01%	469
2020 Q2	$3K	Hold	22	–	–	﹤0.01%	463
2020 Q1	$3K	Buy	22 +11	+100%	+$1.43K	﹤0.01%	438
2019 Q4	$2K	Buy	+11	New	+$1.22K	﹤0.01%	420

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bellevue Asset Management's ASND Position: Q1 2026 in Review

Bellevue Asset Management sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 10 shares — an estimated $2.13K sold.

Bellevue Asset Management first reported a position in ASND in Q4 2019 and held it in 25 quarters. The position peaked at $4K in Q4 2020. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Bellevue Asset Management reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
Bellevue Asset Management sold 10 Ascendis Pharma A/S shares in Q1 2026, an estimated $2.13K.
Bellevue Asset Management first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 25 quarters.
Bellevue Asset Management's Ascendis Pharma A/S position peaked at $4K in Q4 2020.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.